For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Group I (Pain Management) | See detailed description. Acupuncture Therapy: Undergo acupuncture therapy Cancer Pain Management: Receive pain clinic referral Cognitive Behavior Therapy: Undergo CBT Educational Intervention: Receive self-guided pain management education materials Exercise: Participate in exercise Interview: Complete interview Massage Therapy: Receive massage Mindfulness Relaxation: Practice mindfulness Pain Therapy: Receive pain treatment/medicine Palliative Therapy: Receive palliative care referral Patient Navigation: Undergo visits with PCM and CHW for pain management Referral: Receive pain management referrals Spiritual Therapy: Receive spiritual support Spiritual Care Referral: Receive spiritual care referral Survey Administration: Ancillary studies | 0 | None | 0 | 51 | 0 | 51 | View |
| Group II (Intervention Providers) | Group II participants were not enrolled to the study and participated only in study development. | 0 | None | 0 | 0 | 0 | 0 | View |
| Group III (Medical Oncology Providers) | Group III participants were not enrolled to the study and participated only in study development. | 0 | None | 0 | 0 | 0 | 0 | View |